The Latest in Hepatitis

Eight-week, three-drug regimen produces SVR over 90% in HCV

November 14, 2015

Hepatitis

Sofosbuvir plus velpatasvir effective at treating HCV genotype 1 and 3 patients

November 10, 2015

Hepatitis

Sofosbuvir-velpatasvir combo effective in treatment-naive HCV patients*

November 10, 2015

Hepatitis

IDWeek: Despite better drugs, HCV deaths keep rising

October 19, 2015

Hepatitis

High ALT/AST ratio linked to fatty liver risk in HCV

October 13, 2015

Hepatitis

Sofosbuvir reduces liver fibrosis in chronic hepatitis C

October 9, 2015

Hepatitis

Hepatitis C drove steep rises in cirrhosis, HCC, and related deaths

October 6, 2015

Hepatitis

PCORI approves $83 million for HCV, rare disease research

September 29, 2015

Hepatitis

Sofosbuvir-velpatasvir combo effective in all HCV genotypes

September 23, 2015

Hepatitis

Integrated care overcomes HCV treatment barriers

September 8, 2015

Hepatitis

Virologic response no protection against HCV liver decompensation

September 3, 2015

Hepatitis

Cirrhosis in HCV often goes unreported

August 29, 2015

Hepatitis

Measures predict outcomes of chronic HCV with compensated cirrhosis

January 21, 2015

Hepatitis

Sofosbuvir and ribavirin effective in transplant patients with compensated recurrent HCV

January 20, 2015

Hepatitis

Sofosbuvir and ribavirin prevent HCV recurrence after liver transplantation

January 20, 2015

Hepatitis